ME23andMe Holding Co.

Nasdaq 23andme.com


$ 0.50 $ -0.01 (-2.45 %)    

Friday, 10-May-2024 15:59:52 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.4975
$ 0.50
$ 0.50 x 600
$ 0.00 x 0
$ 0.48 - $ 0.51
$ 0.35 - $ 2.20
3,040,646
na
239.2M
$ 1.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-07-2024 12-31-2023 10-Q
2 11-08-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-25-2023 03-31-2023 10-K
5 02-08-2023 12-31-2022 10-Q
6 11-07-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-27-2022 03-31-2022 10-K
9 02-11-2022 12-31-2021 10-Q
10 11-10-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 06-03-2021 03-31-2021 10-Q
13 03-24-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 23andme-holding-granted-additional-180-days-or-until-nov-4-to-regain-compliance-with-minimum-bid-price-requirement-for-continued-listing

-SEC Filing

 23andme-to-present-preliminary-efficacy-and-biomarker-data-for-23me-00610-at-the-2024-asco-annual-meeting

23andMe Holding Co. (NASDAQ:ME) ("23andMe"), a leading human genetics and biopharmaceutical company, today announced th...

 once-valued-at-billions-23andmes-ceo-considers-privatization-to-secure-companys-future

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a fo...

 23andme-reveals-ceos-intention-to-pursue-potential-take-private

Wojcicki currently owns shares constituting more than 20% of the total outstanding shares and entitling her to approximately 49...

 citigroup-maintains-neutral-on-23andme-holding-lowers-price-target-to-047

Citigroup analyst Daniel Grosslight maintains 23andMe Holding (NASDAQ:ME) with a Neutral and lowers the price target from $0...

 23andme-to-present-data-on-two-clinical-stage-immuno-oncology-programs-at-the-aacr-annual-meeting-2024

23ME-01473, antibody targeting ULBP6: Data will be presented on the discovery and biology of ULBP6, and the potential to restor...

 why-intuitive-machines-shares-are-trading-lower-by-around-30-here-are-20-stocks-moving-premarket

Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Fr...

 former-youtube-ceos-teenaged-son-found-dead-at-uc-berkeley

The 19-year-old's grandmother, Esther Wojcicki, known as the "Godmother of Silicon Valley," says his death was like...

 crude-oil-gains-3-kellanova-posts-upbeat-results

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 30 points on Thursday. The Dow tr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION